ALICIA SOULE: Open Payments
NPI 1710381751 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 33 payments from 14 companies in 2025. Trend: 2023 $453 · 2024 $915 · 2025 $840
Food & beverage: $775Education: $65
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $252 |
| Janssen Biotech, Inc. | 5 | $136 |
| Incyte Corporation | 3 | $102 |
| ABBVIE INC. | 3 | $63 |
| PFIZER INC. | 2 | $46 |
| Eisai Inc. | 2 | $41 |
| Stemline Therapeutics Inc. | 1 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Tempus AI, Inc | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
Products named: ENHERTU, LYNPARZA, ERLEADA, DATROWAY, EPKINLY, Lenvima, Orserdu, DARZALEX.
Industry payments across WA — which companies pay providers there.
